"Most Americans who end pregnancies rely on the medications mifepristone and misoprostol, which account for more than half of all abortions nationwide."
"Recent research by the Guttmacher Institute showed that the number of abortions in the U.S. has held steady, with telehealth access explaining an increase in the number of procedures in ban states."
"If the Trump administration doesn't introduce new restrictions on abortion medication, federal judges will likely do the job instead."
"Prominent anti-abortion groups asked the incoming Trump Food and Drug Administration to impose new national restrictions on mifepristone."
Abortion access in the U.S. has remained stable over the past year, with mifepristone and misoprostol accounting for over half of all abortions. Telehealth has contributed to an increase in procedures, particularly in states with bans. While conservative states are pushing for action, recent federal court rulings have maintained the status quo. Trump has not imposed new restrictions on abortion medication, despite pressure from anti-abortion groups. The future of abortion medication regulation remains uncertain as federal judges may intervene if the administration does not act.
Read at Slate Magazine
Unable to calculate read time
Collection
[
|
...
]